GAMMA Investing LLC Takes $26,000 Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

GAMMA Investing LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 319 shares of the company’s stock, valued at approximately $26,000.

A number of other hedge funds have also recently bought and sold shares of the company. Fifth Third Bancorp boosted its position in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after acquiring an additional 136 shares during the last quarter. Estate Counselors LLC boosted its position in Acadia Healthcare by 0.9% during the third quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock worth $1,154,000 after acquiring an additional 145 shares during the last quarter. Tranquility Partners LLC boosted its position in Acadia Healthcare by 5.3% during the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after acquiring an additional 170 shares during the last quarter. Mackenzie Financial Corp boosted its position in Acadia Healthcare by 1.3% during the third quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock worth $1,063,000 after acquiring an additional 199 shares during the last quarter. Finally, Advisor Partners II LLC boosted its position in Acadia Healthcare by 7.5% during the third quarter. Advisor Partners II LLC now owns 3,351 shares of the company’s stock worth $236,000 after acquiring an additional 234 shares during the last quarter.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.00% of the company’s stock.

Acadia Healthcare Price Performance

ACHC opened at $67.78 on Tuesday. The company has a 50-day moving average of $76.42 and a 200-day moving average of $77.45. The company has a market capitalization of $6.29 billion, a P/E ratio of -484.11, a PEG ratio of 1.96 and a beta of 1.31. Acadia Healthcare Company, Inc. has a 1-year low of $64.74 and a 1-year high of $87.77. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. During the same quarter in the previous year, the firm earned $0.75 EPS. The company’s revenue was up 9.1% on a year-over-year basis. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.56 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a research note on Thursday, April 25th. Bank of America cut their price objective on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. TD Cowen boosted their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Finally, Mizuho cut their price objective on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $88.89.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.